CellAegis Devices has obtained Health Canada's marketing authorization for its proprietary, automated, noninvasive device autoRIC device for remote ischemic conditioning (RIC). The Medical Device Class III license, granted by Health ...
AMTAC Certification Services has granted CE mark for CellAegis Devices's autoRIC device. The CE mark allows CellAegis to sell autoRIC Device to 32 member countries and seven cooperating countries of the european economic area, under ...
Tags: AMTAC, CE Mark, medical device
CellAegis Devices has obtained Health Canada's investigational testing (ITA) approval to initiate a pilot clinical trial of its noninvasive autoRIC device for remote ischemic conditioning (RIC). The CE-marked device is placed around ...
Tags: Health Canada, ITA, clinical trial, RIC